See All Slides - tctmd.com

Slides

Presentation TCT 2012

Progress with a Hollow-Core Zotarolimus-Filled Stent (Medtronic)

Presenter: Josiah Wilcox

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

The HDL Hypothesis: A Critical Reappraisal

Presenter: Robert Wilensky

October 23, 2012

Presentation TCT 2012

ELM Presentation(5)

Presenter: Navin Kapur

October 23, 2012

Presentation TCT 2012

Case Example: How Severe Is the MR in this Patient?

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

Vessel Rupture and Perforation: Frequency, Locations and Management

Presenter: Zvonimir Krajcer

October 23, 2012

Presentation TCT 2012

MitraClip Registries: ACCESS-EU, GERMAN Registry, ESC Registry, High-Risk Registry, and REALISM: What Have We Learned Recently?

Presenter: Francesco Maisano

October 23, 2012

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

Pro: Radial!

Presenter: Robert Applegate

October 23, 2012

Advertisement

Slides

Progress with a Hollow-Core Zotarolimus-Filled Stent (Medtronic)

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

The HDL Hypothesis: A Critical Reappraisal

ELM Presentation(5)

Case Example: How Severe Is the MR in this Patient?

Vessel Rupture and Perforation: Frequency, Locations and Management

MitraClip Registries: ACCESS-EU, GERMAN Registry, ESC Registry, High-Risk Registry, and REALISM: What Have We Learned Recently?

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Pro: Radial!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content